VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1371/journal.pone.0168096
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2017
- Creator
-
Sethi, Maya K.
Thol, Felicitas
Stadler, Michael
Heuser, Michael
Ganser, Arnold
Koenecke, Christian
Pabst, Oliver
- DOI
-
10.18154/RWTH-2017-02162
- URN
-
urn:nbn:de:101:1-2018101606092880318890
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sethi, Maya K.
- Thol, Felicitas
- Stadler, Michael
- Heuser, Michael
- Ganser, Arnold
- Koenecke, Christian
- Pabst, Oliver
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2017
Other Objects (12)
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Neurologic complications of the central nervous system after allogeneic hematopoietic stem cell transplantation
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Neurologic complications of the central nervous system after allogeneic hematopoietic stem cell transplantation
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Neurologic complications of the central nervous system after allogeneic hematopoietic stem cell transplantation